This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
這位名創優品集團分析師開始發表看好評論；以下是週五的前5項初始行動
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- Goldman Sachs analyst David Roman initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a Neutral rating and announced a price target of $46. Tandem Diabetes Care shares fell 1.7% to close at $40.46 on Thursday. See how other analysts view this stock.
- Raymond James analyst Laura Prendergast initiated coverage on Mural Oncology plc (NASDAQ:MURA) with a Strong Buy rating and announced a price target of $18. Mural Oncology shares gained 2.6% to close at $3.20 on Thursday. See how other analysts view this stock.
- Canaccord Genuity analyst George Gianarikas initiated coverage on ASP Isotopes Inc. (NASDAQ:ASPI) with a Buy rating and announced a price target of $4.5. ASP Isotopes shares gained 11.1% to close at $3.01 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Michael Mueller initiated coverage on Curbline Properties Corp. (NYSE:CURB) with a Overweight rating and announced a price target of $25. Curbline Properties shares gained 4.3% to close at $22.60 on Thursday. See how other analysts view this stock.
- Citigroup analyst Xiaopo Wei initiated coverage on MINISO Group Holding Limited (NYSE:MNSO) with a Buy rating and announced a price target of $26.8. MINISO Group shares fell 0.2% to close at $18.96 on Thursday. See how other analysts view this stock.
- 高盛分析師David Roman開始對tandem diabetes care公司（納斯達克:TNDM）進行覆蓋，給予中立評級，並公佈目標價爲46美元。tandem diabetes care股價週四下跌1.7%，收於40.46美元。看看其他分析師如何看待這隻股票。
- Raymond James分析師Laura Prendergast開始對mural oncology股份有限公司（納斯達克:MURA）進行覆蓋，給予強烈買入評級，並宣佈目標價爲18美元。mural oncology股價週四上漲2.6%，收於3.20美元。看看其他分析師如何看待這隻股票。
- Canaccord Genuity分析師George Gianarikas開始對asp isotopes公司（納斯達克:ASPI）進行覆蓋，給予買入評級，並宣佈目標價爲4.5美元。asp isotopes股價週四上漲11.1%，收於3.01美元。看看其他分析師如何看待這隻股票。
- JP Morgan分析師Michael Mueller開始對curbline properties公司（紐交所:CURB）進行覆蓋，給予超配評級，並宣佈目標價爲25美元。curbline properties股價週四上漲4.3%，收於22.60美元。看看其他分析師如何看待這隻股票。
- 花旗集團分析師Xiaopo Wei開始對名創優品(臨時代碼)集團控股有限公司（紐交所:MNSO）進行覆蓋，給予買入評級，並宣佈目標價爲26.8美元。名創優品(臨時代碼)集團股價週四下跌0.2%，收於18.96美元。看看其他分析師如何看待這隻股票。
Considering buying MNSO stock? Here's what analysts think:
考慮購買名創優品(臨時代碼)股票嗎？以下是分析師的看法：
- Dow Tumbles Nearly 200 Points Amid Growing Middle East Concerns: Investor Optimism Declines, Fear Index Remains In 'Greed' Zone
- 道指因中東局勢不安而下跌近200點：投資者樂觀情緒下降，恐懼指數仍處於'貪婪'區域
資訊熱榜
更新時間